 |
Courtesy Publications Division of the American
Chemical Society. |
In a report presented at the 248th National Meeting of the
American Chemical Society (ACS), Dipanjan Pan, Ph.D outlined
the group’s efforts of using nanotechnology to deliver bee, snake or scorpion venom directly to tumors.
The nanoparticles are loaded with the venom, and delivers it to the tumor while eluding the immune system. The venoms don’t kill the tumor, rather proteins in the venoms bind to the cancer cell membranes and block the growth and spread of the cancer. In one laboratory study using bee venom, the researchers isolated a protein in the venom called melittin that blocked the cancer cells from multiplying.
the group’s efforts of using nanotechnology to deliver bee, snake or scorpion venom directly to tumors.
The nanoparticles are loaded with the venom, and delivers it to the tumor while eluding the immune system. The venoms don’t kill the tumor, rather proteins in the venoms bind to the cancer cell membranes and block the growth and spread of the cancer. In one laboratory study using bee venom, the researchers isolated a protein in the venom called melittin that blocked the cancer cells from multiplying.
The next step in the research is to test the treatment in
animals. Pan said that if those tests go well, testing in humans could begin in
three to five years.
The American Chemical Society is a nonprofit organization
chartered by the U.S. Congress. With more than 161,000 members, ACS is the
world's largest scientific society.
No comments:
Post a Comment